<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Family Allergy & Asthma Robotics Portfolio</title>
<style>
    body {
        font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        background-color: #f4f7f9;
        color: #333;
        line-height: 1.6;
        margin: 0;
        padding: 20px;
    }
    .container {
        max-width: 900px;
        margin: 0 auto;
        background-color: #ffffff;
        box-shadow: 0 4px 20px rgba(0,0,0,0.08);
        border-radius: 12px;
        overflow: hidden;
    }
    .header {
        background: linear-gradient(135deg, #0056b3 0%, #00a8e8 100%);
        color: white;
        padding: 40px;
        text-align: center;
    }
    .header h1 {
        margin: 0;
        font-size: 2.5em;
        font-weight: 300;
        letter-spacing: 1px;
    }
    .header p {
        margin-top: 10px;
        font-size: 1.1em;
        opacity: 0.9;
    }
    .section {
        padding: 30px 40px;
        border-bottom: 1px solid #eee;
    }
    .section-title {
        color: #0056b3;
        font-size: 1.4em;
        font-weight: 600;
        margin-bottom: 20px;
        text-transform: uppercase;
        letter-spacing: 1px;
        display: flex;
        align-items: center;
    }
    .section-title::after {
        content: '';
        flex: 1;
        height: 1px;
        background: #e0e0e0;
        margin-left: 15px;
    }
    .grid-container {
        display: grid;
        grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
        gap: 20px;
        margin-bottom: 20px;
    }
    .card {
        background: #f8fbff;
        border-left: 4px solid #00a8e8;
        padding: 20px;
        border-radius: 0 8px 8px 0;
    }
    .card h3 {
        margin-top: 0;
        color: #2c3e50;
        font-size: 1.1em;
    }
    .stat-box {
        background: #fff;
        border: 1px solid #e1e8ed;
        border-radius: 8px;
        padding: 15px;
        text-align: center;
    }
    .stat-value {
        font-size: 2em;
        font-weight: bold;
        color: #0056b3;
        display: block;
    }
    .stat-label {
        font-size: 0.85em;
        color: #7f8c8d;
        text-transform: uppercase;
    }
    .roadmap-step {
        display: flex;
        margin-bottom: 15px;
    }
    .step-number {
        background: #0056b3;
        color: white;
        width: 30px;
        height: 30px;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-weight: bold;
        margin-right: 15px;
        flex-shrink: 0;
    }
    .step-content strong {
        display: block;
        color: #2c3e50;
        margin-bottom: 4px;
    }
    .table-custom {
        width: 100%;
        border-collapse: collapse;
        margin-top: 10px;
    }
    .table-custom th {
        text-align: left;
        background: #f0f4f8;
        padding: 12px;
        color: #555;
        font-weight: 600;
        font-size: 0.9em;
    }
    .table-custom td {
        padding: 12px;
        border-bottom: 1px solid #eee;
        font-size: 0.95em;
    }
    .badge-high {
        background-color: #e6f7ff;
        color: #0056b3;
        padding: 4px 8px;
        border-radius: 4px;
        font-size: 0.8em;
        font-weight: bold;
    }
</style>
</head>
<body>

<div class="container">
    <div class="header">
        <h1>Family Allergy & Asthma</h1>
        <p>Robotics Opportunities & ROI Analysis Portfolio</p>
    </div>

    <div class="section">
        <div class="section-title">Executive Summary</div>
        <p>Family Allergy & Asthma (100+ locations) faces operational bottlenecks in manual antigen mixing and patient throughput. This analysis identifies <strong>Centralized Robotic Compounding</strong> as the dominant value driver, offering a potential <strong>$4Mâ€“$6.5M annual net benefit</strong> by standardizing production and reallocating clinical labor.</p>
    </div>

    <div class="section">
        <div class="section-title">High-Value Opportunity Pathways</div>
        <div class="grid-container">
            <div class="card">
                <h3>Pathway A: Robotic Compounding</h3>
                <p><strong>Focus:</strong> Centralized Lab Automation</p>
                <p>Automated robots for mixing patient-specific antigen vials. Replaces manual syringe work, ensures precision, and centralizes production.</p>
                <span class="badge-high">Highest ROI</span>
            </div>
            <div class="card" style="border-left-color: #2ecc71;">
                <h3>Pathway B: Supply Chain IoT</h3>
                <p><strong>Focus:</strong> Inventory Automation</p>
                <p>Smart cabinets and RFID tracking for high-cost extracts and biologics. Reduces expiration waste and prevents stockouts.</p>
            </div>
            <div class="card" style="border-left-color: #f1c40f;">
                <h3>Pathway C: Workflow Automation</h3>
                <p><strong>Focus:</strong> Patient Flow Kiosks</p>
                <p>Digital check-in and observation timers for high-volume shot clinics. Improves throughput and safety compliance.</p>
            </div>
        </div>
    </div>

    <div class="section">
        <div class="section-title">Financial Model: Pathway A (Compounding)</div>
        <div class="grid-container">
            <div class="stat-box">
                <span class="stat-value">$4M - $6.5M</span>
                <span class="stat-label">Net Annual Benefit</span>
            </div>
            <div class="stat-box">
                <span class="stat-value">&lt; 14 Months</span>
                <span class="stat-label">Payback Period</span>
            </div>
            <div class="stat-box">
                <span class="stat-value">~75%</span>
                <span class="stat-label">Reduction in Mixing Labor</span>
            </div>
        </div>
        <p style="font-size: 0.9em; color: #666; margin-top: 15px;">
            *Based on network baseline of ~2.6M vials/year and transition from manual mixing (5-7 mins/vial) to robotic mixing (30-60 secs/vial).
        </p>
    </div>

    <div class="section">
        <div class="section-title">Implementation Roadmap</div>
        <div class="roadmap-step">
            <div class="step-number">1</div>
            <div class="step-content">
                <strong>Phase 1: Centralization Pilot (Months 1-6)</strong>
                Establish central hub in primary market; install 2 pilot robots; route volume from 10 clinics to test logistics.
            </div>
        </div>
        <div class="roadmap-step">
            <div class="step-number">2</div>
            <div class="step-content">
                <strong>Phase 2: Network Rollout (Months 7-18)</strong>
                Scale central facility to 80% network volume; integrate with EMR; reduce manual mixing duties at satellite clinics.
            </div>
        </div>
        <div class="roadmap-step">
            <div class="step-number">3</div>
            <div class="step-content">
                <strong>Phase 3: Optimization (Months 18-24)</strong>
                Deploy inventory smart cabinets to remote sites and flow automation kiosks to top 20 busiest locations.
            </div>
        </div>
    </div>

    <div class="section">
        <div class="section-title">Strategic Positioning</div>
        <p>Implementing this portfolio transitions Family Allergy & Asthma from a standard medical practice into a <strong>tech-enabled healthcare logistics platform</strong>. This creates a competitive moat through proprietary centralization and positions the organization for premium valuation in future equity events.</p>
    </div>
</div>

</body>
</html>